KAJIAN PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN DIABETES MELITUS TIPE 2 DI INSTALASI RAWAT INAP BLU RSUP PROF. DR. R. D. KANDOU MANADO PERIODE JANUARI-DESEMBER 2010

Authors

  • Dian Ansa
  • Lily Goenawi
  • Heedy Tjitrosantoso

DOI:

https://doi.org/10.35799/pha.1.2012.441

Abstract

Hypertension in patient with type 2 diabetes mellitus (DM type 2) improve microvascular and
macrovascular complications. Control of blood pressure can reduce the risk of complication and
mortality. The aims of the study was to assess antihypertensive in patients with type 2 diabetes at
BLU. RSUP. Prof. Dr. R. D. Kandou Manado, from January to December 2010. This study was a
retrospective descriptive study. The data was collected by purposive at the installation of medical
records BLU. RSUP. Prof. Dr. R. D. Kandou Manado, from October to December 2011, and a total of
41 diabetic patients involve in this study. The findings of ths study showed that the majority patients
type 2 diabetes in the age range between 45 to 64 years (70,73%). Patterns of antihypertensive
therapy consists of monotherapy (53,66%) and combination (46,34%). In the monotherapy, which is
often used Angiotensin Converting Inhibitors (ACE-I) (31,82%), Calcium Channel Blockers (CCB)
(27,27%), and Angiotensin Receptor Blocker (ARB) (22,73%). For the combination therapy group,
which is often used combination of ACE-I and CCB, ARB and CCB each one(21,05%), and
combination ACE-I and ARB (15,83%).
Key words: hypertension, type 2 diabetes mellitus, hypertension treatment.

Downloads

Published

2012-08-01

How to Cite

Ansa, D., Goenawi, L., & Tjitrosantoso, H. (2012). KAJIAN PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN DIABETES MELITUS TIPE 2 DI INSTALASI RAWAT INAP BLU RSUP PROF. DR. R. D. KANDOU MANADO PERIODE JANUARI-DESEMBER 2010. PHARMACON, 1(1). https://doi.org/10.35799/pha.1.2012.441

Issue

Vol. 1 No. 1 (2012)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)